Secondary Hyperparathyroidism: Pathophysiology and Treatment

Prevalence of Chronic Kidney Disease in the United States

Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895 · see citing works

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Massry, S. G., Coburn, J. W., Chertow, G. M., Hruska, K. A., Langman, C. B., Malluche, H. H., Martin, K. J., McCann, L. M., McCarthy, J. T., Moe, S. M., et al. (2003) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2,527 · see citing works

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

Block, G. A., Hulbert‐Shearon, T. E., Nw, L., & Port, F. K. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,347 · see citing works

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease

Levin, A., Bakris, G. L., Molitch, M. E., Smulders, M., Tian, J., Williams, L. A., & Andress, D. L. (2006) · Kidney International · doi:10.1038/sj.ki.5002009 · Cited by 1,511 · see citing works

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

Chertow, G. M., Burke, S. K., Raggi, P., & for the Treat to Goal Working Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00434.x · Cited by 1,453 · see citing works

Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Tentori, F., Blayney, M. J., Albert, J. M., Gillespie, B. W., Kerr, P. G., Bommer, J., Young, E. W., Akizawa, T., Akiba, T., Pisoni, R. L., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.020 · Cited by 1,077 · see citing works

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

Teng, M. F., Wolf, M. S., Lowrie, E. G., Ofsthun, N. J., Lazarus, J. M., & Thadhani, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022536 · Cited by 922 · see citing works

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Suki, W. N., Zabaneh, R. I., Cangiano, J. L., Reed, J., Fischer, D., Garrett, L. E., Ling, B., Chasan-Taber, S., Dillon, M. A., Blair, A. T., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002466 · Cited by 525 · see citing works

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Slatopolsky, E., Finch, J. L., Denda, M., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118701 · Cited by 513 · see citing works

Phosphorus Binders and Survival on Hemodialysis

Isakova, T., Accentrrez, O. M. G. A., Chang, Y., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060609 · Cited by 377 · see citing works

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl

Moe, S. M., Chertow, G. M., Coburn, J. W., Quarles, L. D., Goodman, W. G., Block, G. A., Drüeke, T. B., Cunningham, J., Sherrard, D. J., McCary, L. C., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67139.x · Cited by 325 · see citing works

Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease

Palmer, S. C., McGregor, D. O. R., Macaskill, P., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-12-200712180-00004 · Cited by 251 · see citing works

Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients

Shinaberger, C. S., Kilpatrick, R. D., Regidor, D. L., McAllister, C. J., Greenland, S., Kopple, J. D., & Kalantar‐Zadeh, K. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.03.049 · Cited by 249 · see citing works

Hidden Sources of Phosphorus in the Typical American Diet: Does it Matter in Nephrology?

Uribarri, J., & Calvo, M. S. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16037.x · Cited by 241 · see citing works

Calcium-receptor-regulated parathyroid and renal function

Brown, E. M., & Hébert, S. (1997) · Bone · doi:10.1016/s8756-3282(97)00002-1 · Cited by 145 · see citing works

Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients

Finn, W. F. (2006) · Clinical Nephrology · doi:10.5414/cnp65191 · Cited by 131 · see citing works

Adynamic bone in patients with chronic kidney disease

Andress, D. L. (2008) · Kidney International · doi:10.1038/ki.2008.60 · Cited by 129 · see citing works

A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis

Delmez, J. A., Block, G. A., Robertson, J., et al. (2007) · Clinical Nephrology · doi:10.5414/cnp68386 · Cited by 108 · see citing works

Vitamin D and the kidney

Holick, P. D. M. F. (1987) · Kidney International · doi:10.1038/ki.1987.295 · Cited by 106 · see citing works

Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients

Tonelli, M. A., Wiebe, N., Culleton, B. F., Lee, H., Klarenbach, S. W., Shrive, F. M., Manns, B., & for the Alberta Kidney Disease Network (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm421 · Cited by 100 · see citing works

Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4

Sprague, S. M., Abboud, H. E., Qiu, P., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02830608 · Cited by 98 · see citing works

Renal Na/Pi-cotransporters

Biber, J., Custer, M., Magagnin, S., et al. (1996) · Kidney International · doi:10.1038/ki.1996.139 · Cited by 96 · see citing works

Bone and mineral disorders in pre-dialysis CKD

Kovesdy, C. P., & Kalantar‐Zadeh, K. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9346-7 · Cited by 69 · see citing works

A critical evaluation of chronic kidney disease--should isolated reduced estimated glomerular filtration rate be considered a 'disease'?

Poggio, E. D., & Rule, A. D. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn704 · Cited by 67 · see citing works

Calcium acetate as a phosphorus binder in hemodialysis patients.

Delmez, J. A., Tindira, C. A., Windus, D. W., et al. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v3196 · Cited by 55 · see citing works

‘Pulse Oral’ versus Intravenous Calcitriol Therapy in Chronic Hemodialysis Patients

Bacchini, G., Fabrizi, F., Pontoriero, G., et al. (2008) · ˜The œNephron journals/Nephron journals · doi:10.1159/000190286 · Cited by 40 · see citing works

Hypovitaminosis D in Chronic Kidney Disease Patients: Prevalence and Treatment

Cuppari, L., & Garcia-Lopes, M. G. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.005 · Cited by 38 · see citing works

Critical issues of PTH assays in CKD

Komaba, H., Goto, S., & Fukagawa, M. (2008) · Bone · doi:10.1016/j.bone.2008.12.016 · Cited by 16 · see citing works

[Discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis].

Nabeshima, Y. (2008) · PubMed · Cited by 16 · see citing works

Parathyroidectomy in the treatment of secondary hyperparathyroidism in chronic renal failure.

Kostakis, A., Vaiopoulos, G., Kostantopoulos, K., et al. (1997) · PubMed · Cited by 11 · see citing works

Bone and mineral disorders in pre-dialysis CKD

Kovesdy, C. P., & Kalantar‐Zadeh, K. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9389-9 · Cited by 2 · see citing works

A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives

Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441 · see citing works

Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor

Delgado-Calle, J., Tu, X., Pacheco-Costa, R., McAndrews, K., Edwards, R., Pellegrini, G. G., Kuhlenschmidt, K., Olivos, N., Robling, A., Peacock, M., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3011 · Cited by 114 · see citing works

Secondary hyperparathyroidism - an updated view of pathogenic and clinical aspects

Mendonça, D. U., & Carvalho, R. R. S. L. E. A. B. (2002) · Cited by 1 · see citing works

Hyperphosphatemia in Dialysis Patients: The Therapeutic Role of Lanthanum Carbonate

Cozzolino, M. G., & Brancaccio, D. (2007) · The International Journal of Artificial Organs · doi:10.1177/039139880703000403 · Cited by 17 · see citing works

Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism

Cozzolino, M. G., & Brancaccio, D. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.6.947 · Cited by 15 · see citing works

The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia

Jiang, J., Ren, W., Li, Y., et al. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0441-z · Cited by 4 · see citing works

[Long-term suppressive effect of falecalcitriol on parathyroid hormone secretion in secondary hyperparathyroidism in hemodialysis patients].

Iwao, Y., Yamaguchi, Y., Fujii, K., et al. (2006) · PubMed